About

Julian C. Baker has served as an ACADIA director since December 2015. He is a Managing Member of Baker Bros. Advisors LP, a registered investment adviser focused on long-term investments in life-sciences companies, which he co-founded in 2000 with his brother, Felix Baker, Ph.D. He previously was a portfolio manager at Tisch Financial Management and worked in the private-equity arm of Credit Suisse First Boston. He currently serves on the boards of Incyte Corporation, Madrigal Pharmaceuticals and Denali Therapeutics.

Roles

Acadia Pharmaceuticals Inc.
Director · Current role
December 2015–present
Baker Bros. Advisors LP
Managing Member
2000 - present
Tisch Financial Management
Portfolio Manager
1994 - 1999
Credit Suisse First Boston
Private equity investment arm
1988 - 1993

External Roles

Incyte Corporation
Director
Madrigal Pharmaceuticals, Inc.
Director
Denali Therapeutics, Inc.
Director

Director Compensation

FY 2025
Fees earned or paid in cash
$27,952
ComponentAnnual Board and committee cash retainers earned in FY2025
Option awards
$176,392
ComponentAnnual stock option grant, ASC 718 grant-date fair value
Stock awards
$180,705
ComponentAnnual restricted stock unit grant, ASC 718 grant-date fair value
Total
$385,049

Also at Acadia Pharmaceuticals Inc.

Related

See how VectorShift works for your firm

Request Demo